Our earlier work showed that COS supplementation decreased the expression of TLR4 mRNA, and our current work extends these findings by demonstrating that COS supplementation decreased TLR4 protein expression, which indicates that COS supplementation can efficiently activate an inflammatory immune response, thus reducing intestinal infection. This evidence concerns the gene TLR4 and digestive system infectious disorder.